Emerging Infectious Diseases; Vol. 21, No. 11, November 2015
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...ng the use of non-invasive tests and genotype testing; criteria for offering antiviral treatment; the efficacy, safety and cost effectiveness of currently available treatments; selection of first-line therapy; management of treatment failure or drug resistance; prophylactic treatment during im-
munosuppressive therapy; and monitoring for treatment response
more
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
Euro Surveill. 2015 Mar 26;20(12). pii: 21073.
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Retention of knowledge and application within the community one year later
Advocacy report March 2011
303100 03/2011 E 1,000
The tuberculosis survival project .. your cure, your life
Accessed November 2017
Statement
Impact of migration on infectious diseases in Europe | August 2007 | 1-7
Investigación original / Original research
Panam Salud Publica. 2016;39(1):38–43.
Mission report April 2016